{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:45:59Z","timestamp":1788979559619,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccep.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:18:20Z","timestamp":1764159500000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic Risks"],"prefix":"10.1016","volume":"18","author":[{"given":"Ibrahim","family":"Alameh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Kamareddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan-Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccep.2025.09.002_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40265-023-01923-3","article-title":"Recent advances in antiarrhythmic drug therapy","volume":"83","author":"Saljic","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ccep.2025.09.002_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.93.2.372","article-title":"Cellular basis for the electrocardiographic J wave","volume":"93","author":"Yan","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2025.09.002_bib3","first-page":"360","article-title":"Electrocardiographic J wave and J wave syndromes","volume":"8","author":"Yan","year":"2004","journal-title":"Chin J Cardiac Arrhyth"},{"key":"10.1016\/j.ccep.2025.09.002_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4070\/kcj.2016.46.5.601","article-title":"J wave syndromes: history and current controversies","volume":"46","author":"Liu","year":"2016","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ccep.2025.09.002_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.hrthm.2010.12.026","article-title":"Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents","volume":"8","author":"Guo","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2025.09.002_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccep.2010.10.012","article-title":"Overview of basic mechanisms of cardiac arrhythmia","volume":"3","author":"Antzelevitch","year":"2011","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.ccep.2025.09.002_bib7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/pace.14846","article-title":"Mexiletine: antiarrhythmic mechanisms, emerging clinical applications and mortality","volume":"46","author":"Olleik","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0735-1097(10)80210-4","article-title":"Events in the cardiac arrhythmia suppression trial (CAST): mortality in the entire population enrolled","volume":"18","author":"Epstein","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/europace\/euac087","article-title":"Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review","volume":"24","author":"van der Ree","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2025.09.002_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.hrthm.2015.02.013","article-title":"Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization","volume":"12","author":"Qi","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2025.09.002_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.hrthm.2006.04.021","article-title":"Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias","volume":"3","author":"Liu","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2025.09.002_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/cpt.2133","article-title":"Utility of normalized TdP score system in drug proarrhythmic potential assessment: a blinded in vitro study of CiPA drugs","volume":"109","author":"Liu","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccep.2025.09.002_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jelectrocard.2008.07.016","article-title":"T(p-e)\/QT ratio as an index of arrhythmogenesis","volume":"41","author":"Gupta","year":"2008","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FJC.0b013e3181ffe8b3","article-title":"Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes","volume":"57","author":"Guo","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ccep.2025.09.002_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011453","article-title":"Alternating early afterdepolarizations underlying bradycardia-dependent macroscopic T wave and discordant mechanical alternans","volume":"16","author":"Qi","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/pace.12109","article-title":"Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current","volume":"36","author":"Xue","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/cvr\/cvm069","article-title":"Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone","volume":"77","author":"Wu","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ccep.2025.09.002_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.01181.x","article-title":"Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade","volume":"164","author":"Jia","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ccep.2025.09.002_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacep.2015.05.008","article-title":"Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures","volume":"1","author":"Badri","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCULATIONAHA.124.068959","article-title":"Therapeutic efficacy of mexiletine for long QT syndrome type 2: evidence from human induced pluripotent stem cell-derived cardiomyocytes, transgenic rabbits, and patients","volume":"150","author":"Crotti","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2025.09.002_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15517","article-title":"Combined mexiletine and flecainide for severe long QT syndrome type 3","volume":"65","author":"Shimizu","year":"2023","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ccep.2025.09.002_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCEP.113.000092","article-title":"Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome","volume":"6","author":"Gao","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.09.002_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005482","article-title":"Synergistic effect of dofetilide and mexiletine on prevention of atrial fibrillation","volume":"6","author":"Liu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ccep.2025.09.002_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0735-1097(20)31108-6","article-title":"Combination therapy with dofetilide and mexiletine for atrial fibrillation: increased efficacy and decreased QT interval prolongation","volume":"75","author":"Shakir","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0735-1097(03)00713-7","article-title":"Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance","volume":"42","author":"Yan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tcm.2014.09.003","article-title":"Cellular and ionic basis of J-wave syndromes","volume":"25","author":"Badri","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ccep.2025.09.002_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jelectrocard.2005.06.006","article-title":"ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage","volume":"38","author":"Shu","year":"2005","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1542-474X.2005.05588.x","article-title":"ECG repolarization waves: their genesis and clinical implications","volume":"10","author":"Hlaing","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.ccep.2025.09.002_bib29","first-page":"665","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"19","author":"Antzelevitch","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2025.09.002_bib30","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2025.09.002_bib31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2025.09.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.02.011","article-title":"Efficacy of low-dose quinidine in patients with symptomatic Brugada syndrome","author":"Shinohara","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2025.09.002_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hrcr.2024.01.006","article-title":"A representative case of quinidine\u2019s therapeutic effect on Brugada syndrome and the negative impact of the lack of availability in some countries, with a brief note on the lack of benefit of cilostazol","volume":"10","author":"Estrada-Magana","year":"2024","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.ccep.2025.09.002_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.hrcr.2021.09.003","article-title":"Inverse decremental conduction heralds complete atrioventricular block following transcatheter aortic valve replacement","volume":"7","author":"Yan","year":"2021","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.ccep.2025.09.002_bib35","article-title":"A puzzling electrocardiographic phenomenon following transcatheter aortic valve replacement","volume":"6","author":"Zhang","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.ccep.2025.09.002_bib36","article-title":"Wandering bundles with sinus arrhythmia","volume":"15","author":"Yan","year":"2023","journal-title":"JACC Case Rep"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:53:26Z","timestamp":1773924806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918225000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1877918225000644"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2025.09.002","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic Risks","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}